Interventions for HIV-associated nephropathy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Yahaya, Ismail ^a,b   Uthman, Abdulrahman Olalekan ^a   Uthman, Muhammed Mubashir B ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Save the Youth Initiative   (Nigeria)

^c UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Aids associated nephropathy *therapy ; Humans

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRETROVIRUS AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELFINAVIR; PREDNISOLONE; RETINOID; SAQUINAVIR; STAVUDINE; STEROID; VALSARTAN;

CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; FOCAL GLOMERULOSCLEROSIS; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KIDNEY DISEASE; KIDNEY FAILURE; MORTALITY; NONHUMAN; REVIEW; RISK BENEFIT ANALYSIS; SYMPTOM; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 77950162302     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007183.pub2     Document Type: Review

References (41)

1. Burns 1997 {published data only} Burns GC, Paul SK, Toth IR, Sivak SL. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. Journal of the American Society of Nephrology 1997;8(7):1140-6. [MEDLINE: 9219164]
2. Cosgrove 2002 {published data only} Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. American Journal of the Medical Sciences 2002;323(2): 102-6. [MEDLINE: 11863077]
3. Eustace 2000 {published data only} Eustace JA, Nuermberger E, Choi M, Scheel PJ, Moore R, Briggs WA. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney International 2000;58(3): 1253-60. [MEDLINE: 10972688]
4. Kalayjian 2008 {published data only} Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, et al.Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008;22(4):481-7. [MEDLINE: 18301060]
5. Kimmel 1996 {published data only} Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. American Journal of Kidney Diseases 1996;28(2):202-8. [MEDLINE: 8768914]
6. Smith 1994 {published data only} Smith M, Pawar R, Carey J, Graham R, Jacobs G, Menon A, et al.Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy (HIV-AN). American Journal of Medicine 1994;97(2):145-51. [MEDLINE: 8059780]
7. Smith 1996 {published data only} Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, et al.Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. American Journal of Medicine 1996;101(1):41-8. [MEDLINE: 8686713]
8. Szczech 2006 {published data only} Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al.The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney International 2004;66(3):1145-52. [MEDLINE: 15327410]
9. Wei 2003 {published data only} Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney International 2003;64(4):1462-71. [MEDLINE: 12969167]
10. NCT00000819 {unpublished data only} NCT00000819. A phase II randomised, double-blind, placebo-controlled trial to determine the efficacy of prednisolone therapy in HIV-Associated Nephropathy (HIVAN). http://www.clinicaltrials.gov/ (accessed July 2009).
11. NCT00002397 {unpublished data only} NCT00002397. A study of Saquinavir soft gel capsules (SGC) used in combination with two other anti-HIV drugs in patients with HIV-Associated kidney disease. http://www.clinicaltrials.gov/ (accessed July 2009).
12. NCT00089518 {published data only} NCT00089518. Optimal treatment for kidney disease in HIV infected adults. http://clinicaltrials.gov (accessed July 2009).
13. NCT00098020 {unpublished data only} NCT00098020. Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis. http://www.clinicaltrials.gov/ (accessed July 2009).
14. Abbott 2001 Abbott KC, Hypolite I, Welch PG, Agodoa LY. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. Journal of Nephrology 2001;14(5): 377-83. [MEDLINE: 11730270]
15. Ahuja 1999 Ahuja TS, Borucki M, Funtanilla M, Shahinian V, Hollander M, Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing?. American Journal of Nephrology 1999;19(6):655-9. [MEDLINE: 10592359]
16. Atta 2006 Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, et al.Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrology Dialysis Transplantation 2006; 21(10):2809-13. [MEDLINE: 16864598]
17. Atta 2008 Atta MG, Lucas GM, Fine DM. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management. Expert Review of Antiinfective Therapy 2008;6(3):365-71. [MEDLINE: 18588500]
18. Berliner 2008 Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, et al.Observations on a cohort of HIV-infected patients undergoing native renal biopsy. American Journal of Nephrology 2008;28(3):478-86. [MEDLINE: 18176076]
19. Carbone 1989 Carbone L, D'Agati V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. American Journal of Medicine 1989;87(4):389-95. [MEDLINE: 2801729]
20. Estrella 2006 Estrella ME, Fine DM, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, et al.HIV Type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clinical Infectious Diseases 2006;43(3):1488-95. [MEDLINE: 16804855]
21. Fine 2008 Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 2008;68(7):963-80. [MEDLINE: 18457462]
22. Gerntholtz 2006 Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney International 2006;69(10): 1885-91. [MEDLINE: 16625149]
23. Hammer 2008 Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, et al.Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008;300(5):555-70. [MEDLINE: 18677028]
24. Han 2006 Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney International 2006;69(12): 2243-50. [MEDLINE: 16672914]
25. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120]
26. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008. Available from www.cochrane-handbook.org.
27. Ingulli 1991 Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. Journal of Pediatrics 1991;119(5):710-6. [MEDLINE: 1941375]
28. Khan 2006 Khan S, Haragsim L, Laszik ZG. HIV-associated nephropathy. Advances in Chronic Kidney Disease 2006;13(3):307-13. [MEDLINE: 16815235]
29. Kopp 2003 Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney International - Supplement 2003, (83):S43-9. [MEDLINE: 12864874]
30. Lai 2006 Lai CF, Huang JW, Lin WC, Hung CC, Chu TS. Human immunodeficiency virus-associated nephropathy. Journal of the Formosan Medical Association 2006;105(8):680-4. [MEDLINE: 16935771]
31. Lefebvre 2008 Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochranehandbook.org.
32. Lochner 2006 Lochner ML,Wolf A. Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 2006;33(3): 259-67. [MEDLINE: 16859198]
33. Lu 2005 Lu TC, Ross M. HIV-associated nephropathy: a brief review. Mount Sinai Journal of Medicine 2005;72(3):193-9. [MEDLINE: 15915314]
34. Lucas 2004 Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18 (3):541-6. [MEDLINE: 15090808]
35. Master List 2009 United States Cochrane Center. Master list of journals being searched. http://apps1.jhsph.edu/cochrane/masterlist.asp (accessed July 2009).
36. Rao 1984 Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, et al.Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. New England Journal of Medicine 1984;310(11):669-73. [MEDLINE: 6700641]
37. Renal Group 2009 Willis NS, Mitchell R, Higgins GY, Webster AC, Craig JC. Cochrane Renal Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2009, Issue 3. Art. No.: RENAL (accessed July 2009).
38. Roling 2006 Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clinical Infectious Diseases 2006;42(10): 1488-95. [MEDLINE: 16619164]
39. Szczech 2004 Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Gooze L, et al.Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clinical Infectious Diseases 2004;39(8): 1199-206. [MEDLINE: 15486845]
40. Winston 1999 Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney International 1999;55(3):1036-40. [MEDLINE: 10027941]
41. Yahaya 2008 Yahaya I, Uthman AO, Uthman MMB. Adjunctive therapies for HIV-associated nephropathy. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD007183]